Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Levitzki

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Plos One|July 12, 2007
Loss of robustness and addiction to IGF1 during early keratinocyte transformation by human Papilloma virus 16Tamar Geiger, Alexander Levitzki
Advances in Cancer Research|April 11, 2007
Targeted cancer therapy: promise and realityShoshana Klein, Alexander Levitzki
Nature Biotechnology|September 3, 2002
Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKRAlexei Shir, Alexander Levitzki
Molecular Aspects of Medicine|May 11, 2010
Signal transduction therapy of cancerAlexander Levitzki, Shoshana Klein
Current Opinion in Cell Biology|February 14, 2009
Targeting the EGFR and the PKB pathway in cancerShoshana Klein, Alexander Levitzki
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2019
My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancerAlexander Levitzki, Shoshana Klein
Oncogene|December 17, 2002
Cisplatin-induced activation of the EGF receptorMoran Benhar, David Engelberg, Alexander Levitzki
The FEBS Journal|April 27, 2007
Subunit S5a of the 26S proteasome is regulated by antiapoptotic signalsYael Gus, Rotem Karni, Alexander Levitzki
EMBO Reports|May 7, 2002
ROS, stress-activated kinases and stress signaling in cancerMoran Benhar, David Engelberg, Alexander Levitzki
European Journal of Biochemistry|June 26, 2003
The inhibition of Ras farnesylation leads to an increase in p27Kip1 and G1 cell cycle arrestHadas Reuveni, Shoshana Klein, Alexander Levitzki
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Plos One|July 12, 2007
Loss of robustness and addiction to IGF1 during early keratinocyte transformation by human Papilloma virus 16Tamar Geiger, Alexander Levitzki
Advances in Cancer Research|April 11, 2007
Targeted cancer therapy: promise and realityShoshana Klein, Alexander Levitzki
Nature Biotechnology|September 3, 2002
Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKRAlexei Shir, Alexander Levitzki
Molecular Aspects of Medicine|May 11, 2010
Signal transduction therapy of cancerAlexander Levitzki, Shoshana Klein
Current Opinion in Cell Biology|February 14, 2009
Targeting the EGFR and the PKB pathway in cancerShoshana Klein, Alexander Levitzki
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2019
My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancerAlexander Levitzki, Shoshana Klein
Oncogene|December 17, 2002
Cisplatin-induced activation of the EGF receptorMoran Benhar, David Engelberg, Alexander Levitzki
The FEBS Journal|April 27, 2007
Subunit S5a of the 26S proteasome is regulated by antiapoptotic signalsYael Gus, Rotem Karni, Alexander Levitzki
EMBO Reports|May 7, 2002
ROS, stress-activated kinases and stress signaling in cancerMoran Benhar, David Engelberg, Alexander Levitzki
European Journal of Biochemistry|June 26, 2003
The inhibition of Ras farnesylation leads to an increase in p27Kip1 and G1 cell cycle arrestHadas Reuveni, Shoshana Klein, Alexander Levitzki
Pageof 10